About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The group of Clinical Neuroimmunology - Centre d'Esclerosi Múltiple de Catalunya (Cemcat) at the Vall d'Hebron Institut de Recerca (VHIR) is a multidisciplinary group dedicated to clinical assistance, physical and cognitive rehabilitation, and clinical and basic research on multiple sclerosis (MS). Cemcat is a national but also an international reference center in the clinical assistance of MS patients. The research performed in the group is divided and further combined in clinical and basic research. In addition, basic research has a marked translational character since the ultimate goal of the group is to improve the quality of life of patients suffering from MS, through in-depth knowledge of the pathogenic mechanisms of the disease and the development of new and more effective therapeutic approaches.
PMID: 37183551 Journal: LIVER INTERNATIONAL Year: 2023 Reference: Liver Int. 2023 May 15. doi: 10.1111/liv.15606. Impact factor: Publication type: Paper in international publication Authors: Abraldes, Juan G; Albillos, Agustin; Alvarado, Edilmar; Amitrano, Lucio; Banares, Rafael; Bataller, Ramon; Bosch, Jaime; Bureau, Christophe; Calleja, Jose L; Canete, Nuria et al. DOI: 10.1111/liv.15606
PMID: 37089424 Journal: Frontiers in Physiology Year: 2023 Reference: Front Physiol. 2023 Apr 6;14:1145818. doi: 10.3389/fphys.2023.1145818. eCollection 2023. Impact factor: Publication type: Paper in international publication Authors: Bailon, Raquel; Buron, Mathias Due; Comi, Giancarlo; Costa, Gloria Dalla; Cummins, Nicholas; Dobson, Richard J B; Folarin, Amos A; Garcia, Esther; Guerrero, Ana Isabel; Hotopf, Matthew et al. DOI: 10.3389/fphys.2023.1145818
PMID: 37086636 Journal: Multiple Sclerosis and Related Disorders Year: 2023 Reference: Mult Scler Relat Disord. 2023 Apr 17;74:104724. doi: 10.1016/j.msard.2023.104724. Impact factor: Publication type: Paper in international publication Authors: Aldevert, Mireia; Anglada, Elisenda; Arevalo, Maria Jesus; Bascunana, Helena; Curto, Gemma; Feliu, Patricia; Galan, Ingrid; Garcia, Itziar; Garcia, Montserrat; Gonzalo, Lorena et al. DOI: 10.1016/j.msard.2023.104724
PMID: 37816633 Journal: NEUROLOGY Year: 2023 Reference: Neurology. 2023 Oct 10:10.1212/WNL.0000000000207957. doi: 10.1212/WNL.0000000000207957. Impact factor: Publication type: Paper in international publication Authors: Aguayo-Ortiz, Rafael; Akgun, Katja; Arrambide, Georgina; Bassas-Freixas, Patricia; Bermel, Robert A; Bernia-Petit, Eduardo; Bonfill-Orti, Montserrat; Calabresi, Peter A; Canueto, Javier; Deza, Gustavo et al. DOI: 10.1212/WNL.0000000000207957
PMID: 35328838 Journal: International Journal of Environmental Research and Public Health Year: 2022 Reference: Int J Environ Res Public Health. 2022 Mar 8;19(6). pii: ijerph19063150. doi: 10.3390/ijerph19063150. Impact factor: 3.39 Publication type: Paper in international publication Authors: Giovannetti, Ambra Mara, Pottgen, Jana, Menendez, Rebeca, Hoyer, Jurgen, Giordano, Andrea, Pakenham, Kenneth Ian, Galan, Ingrid, Solari, Alessandra, Anglada, Elisenda et al. DOI: 10.3390/ijerph19063150
PMID: 35332015 Journal: AMERICAN JOURNAL OF NEURORADIOLOGY Year: 2022 Reference: AJNR Am J Neuroradiol. 2022 Apr;43(4):534-539. doi: 10.3174/ajnr.A7474. Epub 2022 Mar 24. Impact factor: 3.825 Publication type: Paper in international publication Authors: Caruana, G, Auger, C, Pessini, L M, Calderon, W, de Barros, A, Salerno, A, Sastre-Garriga, J, Montalban, X, Rovira, A et al. DOI: 10.3174/ajnr.A7474
PMID: 34259588 Journal: Multiple Sclerosis Journal Year: 2022 Reference: Mult Scler. 2022 Apr;28(4):654-664. doi: 10.1177/13524585211028561. Epub 2021 Jul 14. Impact factor: 6.312 Publication type: Paper in international publication Authors: Julian, Laura, Montalban, Xavier, Graves, Jennifer, Midaglia, Luciana, Mulero, Patricia, Gossens, Christian, Ganzetti, Marco, Scotland, Alf, Lipsmeier, Florian, van Beek, Johan et al. DOI: 10.1177/13524585211028561
PMID: 33609298 Journal: EUROPEAN JOURNAL OF NEUROLOGY Year: 2022 Reference: Eur J Neurol. 2022 Apr;29(4):1075-1081. doi: 10.1111/ene.14782. Epub 2021 Mar 17. Impact factor: 6.089 Publication type: Paper in international publication Authors: Carbonell-Mirabent, Pere, Zuluaga, Maria, Galan, Ingrid, Rio, Jordi, Arrambide, Georgina, Rodriguez-Barranco, Marta, Vidal-Jordana, Angela, Castillo, Joaquin, Rodriguez-Acevedo, Breogan, Zabalza, Ana et al. DOI: 10.1111/ene.14782
PMID: 32139431 Journal: AMERICAN JOURNAL OF NEURORADIOLOGY Year: 2020 Reference: AJNR Am J Neuroradiol. 2020 Mar;41(3):461-463. doi: 10.3174/ajnr.A6481. Epub 2020 Mar 5. Impact factor: 3.381 Publication type: Paper in international publication Authors: Pareto, D, Garcia-Vidal, A, Alberich, M, Auger, C, Montalban, X, Tintore, M, Sastre-Garriga, J, Rovira, A et al. DOI: 10.3174/ajnr.A6481
PMID: 31918065 Journal: NeuroImage-Clinical Year: 2020 Reference: Neuroimage Clin. 2020;25:102149. doi: 10.1016/j.nicl.2019.102149. Epub 2019 Dec 28. Impact factor: 4.35 Publication type: Paper in international publication Authors: Salem, Mostafa, Valverde, Sergi, Cabezas, Mariano, Pareto, Deborah, Oliver, Arnau, Salvi, Joaquim, Rovira, Alex, Llado, Xavier et al. DOI: 10.1016/j.nicl.2019.102149
PMID: 32094485 Journal: Nature Reviews Neurology Year: 2020 Reference: Nat Rev Neurol. 2020 Mar;16(3):171-182. doi: 10.1038/s41582-020-0314-x. Epub 2020 Feb 24. Impact factor: 27 Publication type: Review in international publication Authors: Palace, Jackie, Sastre-Garriga, Jaume, Pareto, Deborah, Battaglini, Marco, Rocca, Maria A, Ciccarelli, Olga, Enzinger, Christian, Wuerfel, Jens, Sormani, Maria P, Barkhof, Frederik et al. DOI: 10.1038/s41582-020-0314-x
PMID: 32078495 Journal: STROKE Year: 2020 Reference: Stroke. 2020 Apr;51(4):1313-1316. doi: 10.1161/STROKEAHA.119.028787. Epub 2020 Feb 14. Impact factor: 7.19 Publication type: Paper in international publication Authors: Garcia-Tornel, Alvaro, Rubiera, Marta, Requena, Manuel, Muchada, Marian, Pagola, Jorge, Rodriguez-Luna, David, Deck, Matias, Juega, Jesus, Rodriguez-Villatoro, Noelia, Boned, Sandra et al. DOI: 10.1161/STROKEAHA.119.028787
In total, different projects of six research groups will be promoted, focusing on precision medicine and advanced therapies.
Dr. Carmen Espejo and Dr. Georgina Arrambide, researchers at Cemcat and Vall d'Hebron Research Institute, are the first authors of the article.
The research findings propose to modify the McDonald 2017 criteria, only in those in whom diagnosis using the current criteria is not possible.
Simoa HD1 equipment
We are looking for 100 healthy volunteers aged 18 or over to participate in a project where the usefulness of biomarkers in serum will be evaluated to predict the prognosis of the disease and the response to treatments.
